Revolution Medicines (RVMD) Short-term Investments (2019 - 2026)
Revolution Medicines (RVMD) reported Short-term Investments of $3.12 billion for Q2 2026, up 80.0% from $1.73 billion a year earlier and up 112.8% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Short-term Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Revolution Medicines posted Short-term Investments of $1.64 billion, down 6.0% from FY2024.
- Short-term Investments has a five-year compound annual growth rate of 37.3% (FY2020 to FY2025).
- By year, Short-term Investments came in at $1.75 billion in FY2024 (+51.0%), $1.16 billion in FY2023 (+139.2%), $483.53 million in FY2022 (+3.2%) and $468.56 million in FY2021 (+39.3%).
- The Q2 2026 figure ranks as the highest quarterly Short-term Investments in data going back to Q4 2019.
- Year over year, Short-term Investments gained in six of the last eight quarters, with growth averaging 48.6%.
- The high point for year-over-year Short-term Investments in five years was Q3 2024 (growth of 196.4%); the low point was Q2 2022 (a decline of 21.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.47 billion (Q1 2026), $1.64 billion (Q4 2025) and $1.71 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.12 Bn |
| Mar 31, 2026 | 1.47 Bn |
| Dec 31, 2025 | 1.64 Bn |
| Sep 30, 2025 | 1.71 Bn |
| Jun 30, 2025 | 1.73 Bn |
| Mar 31, 2025 | 1.77 Bn |
| Dec 31, 2024 | 1.75 Bn |
| Sep 30, 2024 | 1.35 Bn |
| Jun 30, 2024 | 1.32 Bn |
| Mar 31, 2024 | 1.42 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 454.80 Mn |
| Jun 30, 2023 | 529.16 Mn |
| Mar 31, 2023 | 482.58 Mn |
| Dec 31, 2022 | 483.53 Mn |
| Sep 30, 2022 | 476.07 Mn |
| Jun 30, 2022 | 355.65 Mn |
| Mar 31, 2022 | 421.09 Mn |
| Dec 31, 2021 | 468.56 Mn |
| Sep 30, 2021 | 479.50 Mn |
API Access
Revolution Medicines Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();